AIM
DGX icon

AXA Investment Managers’s Quest Diagnostics DGX Stock Holding History

AXA Investment Managers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$358K Buy
+1,881
New +$334K ﹤0.01% 1029

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AXA Investment Managers's DGX Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Quest Diagnostics (DGX) in Q3 2025: 1,881 shares worth $358K. The stake represents ﹤0.01% of the portfolio and ranks #1029 among its holdings.

1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • AXA Investment Managers held 1,881 shares of Quest Diagnostics worth $358K as of Q3 2025.
  • Quest Diagnostics was a new AXA Investment Managers position in Q3 2025.
  • Quest Diagnostics made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #1029 holding.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.